Foundation stone laid for €400m extension to Eli Lilly drug plant

THE foundation stone was laid yesterday on a €400 million extension to a global drug firm’s Cork plant, which will develop new generation biotech drugs and employ 200 people within five years.

The IDA Ireland-backed investment in the development of a biopharmaceutical manufacturing operation at Eli Lilly’s plant in Dunderrow, Kinsale, will bring total employment at the plant to more than 600.

The new facility will produce medicines to treat illnesses including cancer, diabetes and Alzheimer’s disease in patients around the world.